Mairs and Power’s AMGN Holdings & Trades

First Buy
Q2 2013
Duration Held
50 Quarters
Largest Add
Q2 2013
+11,506 shares
Current Position
5,667 shares
$1.6 M value

Mairs and Power's AMGN Position Overview

Mairs and Power (via Mairs & Power INC) currently holds 5.7K shares of Amgen Inc. (AMGN) worth $1.6 M, representing 0.02% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.

Based on 13F filings since 2013, Mairs and Power has maintained a long-term strategic position in AMGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2018, adding 2.0K shares. Largest reduction occurred in Q2 2024, reducing 1.3K shares.

Analysis based on 13F filings available since 2013 Q2

Mairs and Power's Amgen (AMGN) Holding Value Over Time

Track share changes against reported price movement

Quarterly Amgen (AMGN) Trades by Mairs and Power

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2013 +11,506 Add 0.00% 11,505 $98.65
Q3 2013 -325 Reduce 2.82% 11,180 $111.90
Q4 2013 -400 Reduce 3.58% 10,780 $114.10
Q2 2014 +211 Add 1.96% 10,991 $118.37
Q3 2014 -50 Reduce 0.45% 10,941 $140.48
Q2 2015 -50 Reduce 0.46% 10,891 $153.52
Q3 2015 +275 Add 2.53% 11,166 $138.28
Q4 2015 -75 Reduce 0.67% 11,091 $162.29
Q1 2016 -1,175 Reduce 10.59% 9,916 $149.96
Q1 2017 -1,071 Reduce 10.80% 8,845 $164.05
Q2 2017 -161 Reduce 1.82% 8,684 $172.27
Q3 2017 -555 Reduce 6.39% 8,129 $186.49
Q4 2017 -166 Reduce 2.04% 7,963 $173.93
Q1 2018 +1,985 Add 24.93% 9,948 $170.49
Q2 2018 +271 Add 2.72% 10,219 $184.56
Q3 2018 -646 Reduce 6.32% 9,573 $207.25
Q4 2018 -250 Reduce 2.61% 9,323 $194.68
Q1 2019 -243 Reduce 2.61% 9,080 $189.98
Q2 2019 -300 Reduce 3.30% 8,780 $184.28
Q4 2019 -400 Reduce 4.56% 8,380 $241.05
Q3 2020 +75 Add 0.89% 8,455 $254.17
Q4 2020 +35 Add 0.41% 8,490 $229.92
Q1 2021 -35 Reduce 0.41% 8,455 $248.85
Q2 2021 -75 Reduce 0.89% 8,380 $243.79
Q3 2021 +250 Add 2.98% 8,630 $212.63
Q4 2021 -63 Reduce 0.73% 8,567 $224.93
Q1 2022 +125 Add 1.46% 8,692 $241.83
Q2 2022 +301 Add 3.46% 8,993 $243.30
Q3 2022 -58 Reduce 0.64% 8,935 $225.41
Q4 2022 -36 Reduce 0.40% 8,899 $262.64
Q1 2023 -145 Reduce 1.63% 8,754 $241.75
Q2 2023 -1,117 Reduce 12.76% 7,637 $222.02
Q3 2023 -162 Reduce 2.12% 7,475 $268.76
Q4 2023 -10 Reduce 0.13% 7,465 $288.02
Q1 2024 -180 Reduce 2.41% 7,285 $284.32
Q2 2024 -1,335 Reduce 18.33% 5,950 $312.45
Q3 2024 -2 Reduce 0.03% 5,948 $322.21
Q4 2024 -341 Reduce 5.73% 5,607 $260.64
Q1 2025 -646 Reduce 11.52% 4,961 $311.55
Q2 2025 +877 Add 17.68% 5,838 $279.21
Q3 2025 -171 Reduce 2.93% 5,667 $282.20

Mairs and Power's Amgen Investment FAQs

Mairs and Power first purchased Amgen Inc. (AMGN) in Q2 2013, acquiring 11,505 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Mairs and Power has held Amgen Inc. (AMGN) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Mairs and Power's largest addition to Amgen Inc. (AMGN) was in Q2 2013, adding 11,505 shares worth $1.14 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, Mairs and Power's firm, Mairs & Power INC, owns 5,667 shares of Amgen Inc. (AMGN), valued at approximately $1.6 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, Amgen Inc. (AMGN) represents approximately 0.02% of Mairs and Power's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Mairs and Power's peak holding in Amgen Inc. (AMGN) was 11,505 shares, as reported at the end of Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.